Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7 results about "Suppressed appetite" patented technology

Compositions comprising selective androgen receptor modulator compounds in combination with weight loss drugs and uses thereof for quality weight loss

PendingUS20260069564A1Metabolism disorderPeptide/protein ingredientsDecreased body weightPancreatic hormone
The present invention relates to the field of treatment for body composition changes in weight management. In some embodiments, the present invention provides compositions and methods for mitigating the adverse effects of treatment by weight loss drugs that suppress appetite including incretin agonist or antagonist containing drugs such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) or by sodium-glucose transport protein 2 (SGLT-2) inhibitors.
Owner:VERU INC

Compositions and Methods for Treating Endocrine Diseases and Disorders

Disclosed herein are compounds and ligands, and compositions formed therewith, which modulate insulin secretion, suppress appetite, and reduce body mass by activating G-protein coupled receptors (GPCRs), such as ectopic olfactory receptors, and transient receptor potential (TRP) ion channels. Also disclosed herein are methods for using the compositions to treat endocrine diseases, such as type-2 diabetes and obesity.
Owner:OLFACTIVE AL INC

Solution for promoting fat burning and inhibiting appetite and preparation method thereof

The invention discloses a solution for promoting fat burning and inhibiting appetite and a preparation method thereof. Normal saline is treated through low-temperature plasma (CAP) to become activated normal saline; the activated normal saline contains a large amount of active oxygen and active nitrogen, and after the normal saline is injected into the body, the active ingredients of the normal saline can promote fat burning and inhibit appetite through various ways, so that the effects of reducing fat and losing weight are achieved. Compared with an existing weight-losing mode, the weight-losing composition is free of side effects, quite obvious in effect and short in period. The invention fills up the blank of research on fat burning promotion and appetite inhibition of the plasma activation liquid.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

Weight loss formulations and their use

PendingCN122320995ACarrageenanAgonist
This invention provides a weight-loss formulation for subjects, wherein the active ingredient of the weight-loss formulation is carrageenan. This invention also provides the application of the active ingredient composed of carrageenan in the preparation of the weight-loss formulation for subjects. This invention creatively uses carrageenan alone as an active ingredient for weight loss, achieving very good weight-loss effects. At 24h, 48h, 72h, and 96h after injection, body weight decreased by 9.97% (P<0.05), 10.24% (P<0.05), 11.19% (P<0.01), and 13.21% (P<0.01), respectively, showing a gradually increasing trend, rapid onset, and significant effect. The weight-loss effect is superior to the latest oral weight-loss drug, the small-molecule GLP-1R agonist orforglipron. Furthermore, carrageenan, as an active ingredient, can also suppress appetite, reduce defecation, and increase urination.
Owner:INST OF ACUPUNCTURE & MOXIBUSTION CHINA ACADEMY OF CHINESE MEDICAL SCI

Compositions comprising selective androgen receptor modulator compounds in combination with weight loss drugs and uses thereof for incremental weight loss and management of adverse side effects of weight loss drugs on body composition

The present invention relates to methods for incremental weight loss and to the field of treatment to improve body composition changes and physical function with weight reduction. In some embodiments, the present invention provides compositions and methods for mitigating the adverse effects of treatment by weight loss drugs that suppress appetite including incretin agonist or antagonist containing drugs such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), GIP, glucagon, amylin, or by sodium-glucose transport protein 2 (SGLT-2) inhibitors.
Owner:VERU INC

Compositions comprising selective androgen receptor modulator compounds in combination with weight loss drugs and uses thereof for quality weight loss

The present invention relates to the field of treatment for body composition changes in weight management. In some embodiments, the present invention provides compositions and methods for mitigating the adverse effects of treatment by weight loss drugs that suppress appetite including incretin agonist or antagonist containing drugs such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) or by sodium-glucose transport protein 2 (SGLT-2) inhibitors. In one embodiment, the present invention provides a composition of semaglutide and a selective androgen receptor modulator (SARM) compound of Formula IX.
Owner:VERU INC

Lens surface coating material for visual decoloring and preparation method thereof

PendingCN121271285AVacuum evaporation coatingSputtering coatingSuppressed appetiteBlood sugar
The invention relates to a decoloring material for a lens surface coating film in vision, scenery or food is black and white in human eyes by filtering a specific spectrum so as to inhibit appetite, and the decoloring material is suitable for the field of fat reduction and sugar control. Different from traditional glasses, the color is directly converted into black and white through spectrum filtering, food temptation is reduced, and the brightness and definition of scenery are not changed. Meanwhile, by combining blue light resistance and ultraviolet protection functions, blue light damage to an electronic screen is reduced, ultraviolet rays are blocked, and the anti-blue-light protective film is suitable for long-term use of electronic equipment or use in a strong light environment. In addition, the anti-fog function is introduced, it is ensured that the lens is not fogged in the high-temperature and high-humidity environment, and the sight line is kept clear.
Owner:BEIJING CHENXIHAO INFORMATION TECH CO LTD